Physician profile
Gregroy A Hively
NPI 1619968385
$40,112.97
in general payments reported to CMS, 2019-2025
15 companies · $12K in 2025
The $12K reported for 2025 was more than what 99% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $809 · 2020: $271 · 2021: $968 · 2022: $1,029 · 2023: $13K · 2024: $12K · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $21K · Travel and Lodging: $9,154 · Food and Beverage: $3,911 · Consulting Fee: $3,390.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $20,580.00 |
| Travel and Lodging | $9,154.46 |
| Food and Beverage | $3,911.04 |
| Consulting Fee | $3,390.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $37,818.25 | 2019-2025 | Myday Contact Lens, Clariti Contact Lens, Cvi Contact Lens |
| Alcon Vision LLC | $746.35 | 2019-2025 | Tryptyr, Precision 1 |
| New World Medical,INC. | $376.26 | 2022-2025 | Clearpath, Kahook Dual Blade, Ahmed Glaucoma Valve |
| Abbvie INC. | $255.11 | 2022-2025 | |
| Johnson & Johnson Vision Care, INC. | $233.19 | 2022 | |
| Bausch & Lomb Americas INC. | $161.49 | 2022-2023 | Infuse |
| Sight Sciences, INC. | $147.09 | 2022 | |
| Glaukos Corporation | $102.29 | 2019 | |
| Johnson & Johnson Surgical Vision, INC. | $94.91 | 2019 | |
| Harrow Eye, LLC | $58.23 | 2025 | |
| Allergan, INC. | $56.30 | 2021-2022 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 | |
| Oyster Point Pharma, INC. | $14.74 | 2024 | Ryzumvi, Tyrvaya |
| Novartis Pharmaceuticals Corporation | $12.12 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregroy Hively listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.